Evolution of the Average Target: Clinuvel Pharmaceuticals Limited

Evolution of the Average Target - Clinuvel Pharmaceuticals Limited

Evolution of the Target Price: Clinuvel Pharmaceuticals Limited

Evolution of the Target Price - Clinuvel Pharmaceuticals Limited

Changes in Analyst Recommendations: Clinuvel Pharmaceuticals Limited

32.oVzmkORMPXeT2W6-wvZEmYGd6v_HvAdxBYhLsWCH4E0.1jvQ5JIeaTj5vxv0i8B39-fks7iP_WkaYroM_DX9tmDoa5XUsHhMBaHsWg~3711407c5dd41db3d14fcc450bb54c35

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+132.85%
+8.8%
+4.5%
+11.41%
-0.35%
+21.62%
+1.75%
+23.51%
-0.69%
+5.64%
Average +20.90%
Weighted average by Cap. +8.40%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
7.240AUD
Average target price
16.86AUD
Spread / Average Target
+132.85%
High Price Target
39.30AUD
Spread / Highest target
+442.82%
Low Price Target
7.000AUD
Spread / Lowest Target
-3.31%

Analyst Consensus Detail

Analyst consensus - Clinuvel Pharmaceuticals Limited

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Clinuvel Pharmaceuticals Limited
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - Clinuvel Pharmaceuticals Limited
  1. Stock Market
  2. Stocks
  3. CUV Stock
  4. Consensus Clinuvel Pharmaceuticals Limited